David A. Siegel Forte Biosciences, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Forte Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 24,791 shares of FBRX stock, worth $12,891. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,791
Previous 24,791
-0.0%
Holding current value
$12,891
Previous $20,000
15.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding FBRX
# of Institutions
34Shares Held
19MCall Options Held
1KPut Options Held
0-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$1.88 Million0.57% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$1.7 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$1.55 Million0.06% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$1.06 Million1.95% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$956,2610.01% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $10.6M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.